Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Market Research Future | PRODUCT CODE: 1236128

Cover Image

PUBLISHER: Market Research Future | PRODUCT CODE: 1236128

Pharmacy Management System Market Forecast to 2030

PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Corporate User License)
USD 7250

Add to Cart

Market Dynamics

The pharmacy management system market is expected to register a healthy CAGR of 10.12% by 2030. The system utilized in a pharmacy to assist with computerizing the pharmacy work process is known as pharmacy management programming. This incorporates assessing doctor medicines and getting ready meds, and stock management. The worldwide market development of the pharmacy management system is credited to the ascent in the number of vital drives, and benefits related to pharmacy management systems, and the weight on drug specialists because of the rising number of remedies. Besides, the rising interest in pharmacy management systems in arising economies gives learning experiences to the market from now on. Notwithstanding, complex highlights, for example, vendor security could obstruct the market's development in the conjecture period.

Pharmacy management systems are huge devices with exceptionally powerful and user-friendly management benefits that help drug specialists in overseeing assignments, including stock management, administering prescriptions, and deals capability. These systems additionally permit drug specialists to offer proficient consideration in light of patient necessities. A rising number of vital drives as dispatches, consolidations and acquisitions, coordinated efforts, and joint endeavors are driving the pharmacy management system market.

Segment Overview

By Solution Type, the market is partitioned into Pharmacy Stock Management Software, Pharmacy Information Management Systems, Pharmacy Intensifying Software Systems, Pharmacy Advantage Management, Pharmacy Income Cycle Management System, and Others.

By Component, the fragment separates the market into Software, Hardware, and Services. By Deployment Mode the market is bifurcated into On-Premises and Cloud/Electronic. By End Users, the worldwide market is bifurcated into Ongoing Drug stores and short-term Drug stores. The short-term fragment is further sub-sectioned into quick track centers and emergency clinic retail settings.

Regional Analysis

Americas is expected to register a significant CAGR of 10.29% by the end of 2030. This is credited to expanding mechanical headway, for example, mechanized termination date following, which assists with lessening burn through and saves staff time and so on. As per the American School of Clinical Pharmacy, around 5 billion remedies will be apportioned by 2021, which will build drug specialists' weight; thus, the reception of mechanized arrangements in work process management is normal.

The Europe pharmacy management system market is segregated among France, Germany, the UK, Switzerland, Netherlands, Belgium, Russia, Spain, Italy, Austria, and the remainder of Europe. The advantages presented by pharmacy management empower drug specialists to oversee medication advantageously and bother-free, right from their PC or cell phone. Moreover, rising web infiltration across the region, further developing digitalization of medical care administrations, and the developing number of educated drug specialists are additionally supporting the market development.

Key Players

DataScan Pharmacy (US), Cerner Corporation (US), Allscripts Healthcare, LLC (US), Epicor Software Corporation (US) GlobeMed Group (Lebanon), LS Retail EHF (Iceland), McKesson Corporation (US), Liberty Software, Inc. (US), MedHOK, Inc. (US), Octal IT Solution LLP (India), ScriptPro LLC (US), Clanwilliam Health (Ireland), Safecare Technology (UAE), Mobile MedSoft (US), and Health Business Systems, Inc. (US).

Product Code: MRFR/HC/7091-CR

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE SYSTEM
  • 2.4 MARKET STRUCTURE
  • 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 RISE IN THE NUMBER OF STRATEGIC INITIATIVES
    • 4.2.2 BENEFITS ASSOCIATED WITH PHARMACY MANAGEMENT SYSTEMS
    • 4.2.3 BURDEN ON PHARMACISTS DUE TO INCREASING NUMBER OF PRESCRIPTIONS
  • 4.3 RESTRAINTS
    • 4.3.1 COMPLEX FEATURES SUCH AS VENDOR LOCK-IN
  • 4.4 OPPORTUNITIES
    • 4.4.1 INCREASING DEMAND FOR PHARMACY MANAGEMENT SYSTEMS IN EMERGING ECONOMIES
  • 4.5 CHALLENGES
    • 4.5.1 UNAVAILABILITY OF TRAINED PROFESSIONALS

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 INPUTS
    • 5.1.2 SOFTWARE DEVELOPMENT PROCESSES
    • 5.1.3 OUTPUT
    • 5.1.4 MARKETING AND DISTRIBUTION
    • 5.1.5 POST-SELLING SERVICES
      • 5.1.5.1 SOFTWARE MAINTENANCE SERVICES & AGREEMENTS
      • 5.1.5.2 TRAINING & CERTIFICATIONS
      • 5.1.5.3 SUPPORT: TECHNICAL & GRIEVANCE AID
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE PHARMACY MANAGEMENT SYSTEM MARKET

6 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE

  • 6.1 OVERVIEW
  • 6.2 PHARMACY INVENTORY MANAGEMENT SYSTEM
  • 6.3 PHARMACY DATA MANAGEMENT SYSTEM
  • 6.4 PHARMACY COMPOUNDING SOFTWARE SYSTEM
  • 6.5 PHARMACY BENEFITS MANAGEMENT SYSTEM
  • 6.6 PHARMACY REVENUE CYCLE MANAGEMENT SYSTEM
  • 6.7 OTHERS

7 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY COMPONENT

  • 7.1 OVERVIEW
  • 7.2 SOFTWARE
  • 7.3 HARDWARE
  • 7.4 SERVICES

8 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE

  • 8.1 OVERVIEW
  • 8.2 CLOUD/WEB-BASED
  • 8.3 ON-PREMISE

9 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER

  • 9.1 OVERVIEW
  • 9.2 INPATIENT PHARMACIES
  • 9.3 OUTPATIENT PHARMACIES

10 PHARMACY MANAGEMENT SYSTEMS, BY REGION

  • 10.1 OVERVIEW
  • 10.2 AMERICAS
    • 10.2.1 NORTH AMERICA
      • 10.2.1.1 US
      • 10.2.1.2 CANADA
  • 10.3 EUROPE
    • 10.3.1 WESTERN EUROPE
      • 10.3.1.1 GERMANY
      • 10.3.1.2 FRANCE
      • 10.3.1.3 UK
      • 10.3.1.4 ITALY
      • 10.3.1.5 SPAIN
      • 10.3.1.6 NETHERLANDS
      • 10.3.1.7 SWITZERLAND
      • 10.3.1.8 BELGIUM
      • 10.3.1.9 AUSTRIA
      • 10.3.1.10 REST OF WESTERN EUROPE
    • 10.3.2 EASTERN EUROPE
  • 10.4 ASIA-PACIFIC
    • 10.4.1 JAPAN
    • 10.4.2 CHINA
    • 10.4.3 INDIA
    • 10.4.4 AUSTRALIA
    • 10.4.5 SOUTH KOREA
    • 10.4.6 TAIWAN
    • 10.4.7 NEW ZEALAND
    • 10.4.8 THAILAND
    • 10.4.9 PHILIPPINES
    • 10.4.10 REST OF ASIA-PACIFIC
  • 10.5 MIDDLE EAST & AFRICA
    • 10.5.1 MIDDLE EAST
    • 10.5.2 AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 11.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
    • 11.6.2 MERGER & ACQUISITIONS
    • 11.6.3 AGREEMENT/MARKETING STRATEGIES

12 COMPANY PROFILES

  • 12.1 ALLSCRIPTS HEALTHCARE, LLC
    • 12.1.1 COMPANY OVERVIEW
    • 12.1.2 FINANCIAL OVERVIEW
    • 12.1.3 PRODUCTS OFFERED
    • 12.1.4 KEY DEVELOPMENTS
    • 12.1.5 SWOT ANALYSIS
    • 12.1.6 KEY STRATEGIES
  • 12.2 CERNER CORPORATION
    • 12.2.1 COMPANY OVERVIEW
    • 12.2.2 PRODUCTS OFFERED
    • 12.2.3 PRODUCTS OFFERED
    • 12.2.4 KEY DEVELOPMENTS
    • 12.2.5 SWOT ANALYSIS
    • 12.2.6 KEY STRATEGIES
  • 12.3 DATASCAN PHARMACY
    • 12.3.1 COMPANY OVERVIEW
    • 12.3.2 FINANCIAL OVERVIEW
    • 12.3.3 PRODUCTS OFFERED
    • 12.3.4 KEY DEVELOPMENTS
    • 12.3.5 KEY STRATEGIES
  • 12.4 EPICOR SOFTWARE CORPORATION
    • 12.4.1 COMPANY OVERVIEW
    • 12.4.2 FINANCIAL OVERVIEW
    • 12.4.3 PRODUCTS OFFERED
    • 12.4.4 KEY DEVELOPMENTS
    • 12.4.5 SWOT ANALYSIS
    • 12.4.6 KEY STRATEGIES
  • 12.5 GLOBEMED GROUP
    • 12.5.1 COMPANY OVERVIEW
    • 12.5.2 FINANCIAL OVERVIEW
    • 12.5.3 PRODUCTS OFFERED
    • 12.5.4 KEY DEVELOPMENTS
    • 12.5.5 SWOT ANALYSIS
    • 12.5.6 KEY STRATEGIES
  • 12.6 LIBERTY SOFTWARE, INC.
    • 12.6.1 COMPANY OVERVIEW
    • 12.6.2 FINANCIAL OVERVIEW
    • 12.6.3 PRODUCTS OFFERED
    • 12.6.4 KEY DEVELOPMENTS
    • 12.6.5 KEY STRATEGIES
  • 12.7 LS RETAIL EHF
    • 12.7.1 COMPANY OVERVIEW
    • 12.7.2 FINANCIAL OVERVIEW
    • 12.7.3 PRODUCTS OFFERED
    • 12.7.4 KEY DEVELOPMENTS
    • 12.7.5 KEY STRATEGIES
  • 12.8 MCKESSON CORPORATION
    • 12.8.1 COMPANY OVERVIEW
    • 12.8.2 FINANCIAL OVERVIEW
    • 12.8.3 PRODUCTS OFFERED
    • 12.8.4 KEY DEVELOPMENTS
    • 12.8.5 SWOT ANALYSIS
    • 12.8.6 KEY STRATEGIES
  • 12.9 MEDHOK, INC.
    • 12.9.1 COMPANY OVERVIEW
    • 12.9.2 FINANCIAL OVERVIEW
    • 12.9.3 PRODUCTS OFFERED
    • 12.9.4 KEY DEVELOPMENTS
    • 12.9.5 KEY STRATEGIES
  • 12.10 OCTAL IT SOLUTION LLP
    • 12.10.1 COMPANY OVERVIEW
    • 12.10.2 FINANCIAL OVERVIEW
    • 12.10.3 PRODUCTS OFFERED
    • 12.10.4 KEY DEVELOPMENTS
    • 12.10.5 KEY STRATEGIES
  • 12.11 SAFECARE TECHNOLOGY
    • 12.11.1 COMPANY OVERVIEW
    • 12.11.2 FINANCIAL OVERVIEW
    • 12.11.3 PRODUCTS OFFERED
    • 12.11.4 KEY DEVELOPMENTS
    • 12.11.5 KEY STRATEGIES
  • 12.12 SCRIPTPRO LLC
    • 12.12.1 COMPANY OVERVIEW
    • 12.12.2 FINANCIAL OVERVIEW
    • 12.12.3 PRODUCTS OFFERED
    • 12.12.4 KEY DEVELOPMENTS
    • 12.12.5 KEY STRATEGIES
  • 12.13 CLANWILLIAM HEALTH
    • 12.13.1 COMPANY OVERVIEW
    • 12.13.2 FINANCIAL OVERVIEW
    • 12.13.3 PRODUCTS OFFERED
    • 12.13.4 KEY DEVELOPMENTS
    • 12.13.5 KEY STRATEGIES
  • 12.14 MOBILE MEDSOFT
    • 12.14.1 COMPANY OVERVIEW
    • 12.14.2 FINANCIAL OVERVIEW
    • 12.14.3 PRODUCTS OFFERED
    • 12.14.4 KEY DEVELOPMENTS
    • 12.14.5 KEY STRATEGIES
  • 12.15 HEALTH BUSINESS SYSTEMS, INC.
    • 12.15.1 COMPANY OVERVIEW
    • 12.15.2 FINANCIAL OVERVIEW
    • 12.15.3 PRODUCTS OFFERED
    • 12.15.4 KEY DEVELOPMENTS
    • 12.15.5 KEY STRATEGIES

13 APPENDIX

  • 13.1 REFERENCES
  • 13.2 RELATED REPORTS
Product Code: MRFR/HC/7091-CR

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 4 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY INVENTORY MANAGEMENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY DATA MANAGEMENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY COMPOUNDING SOFTWARE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMA PHARMACY BENEFITS MANAGEMENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY REVENUE CYCLE MANAGEMENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR OTHERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 11 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 15 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR CLOUD/WEB-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 25 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 26 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 27 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 32 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 33 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 34 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37 US: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 38 US: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 39 US: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 40 US: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41 US: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42 US: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 44 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 45 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 46 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 51 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 53 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 58 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 59 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 60 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 64 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 66 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 70 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 72 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75 UK: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 76 UK: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77 UK: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 78 UK: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79 UK: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80 UK: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 82 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 84 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 88 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 90 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 94 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 96 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 100 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 101 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 102 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 106 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 107 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 108 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 112 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 114 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 118 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 119 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 120 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 124 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 125 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 126 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 131 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 132 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 133 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 135 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 136 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 137 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 138 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 139 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 141 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 142 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 143 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 145 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 147 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 148 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 149 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 150 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 151 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 153 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 154 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 155 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 156 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 157 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 159 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 160 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 161 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 162 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 163 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 165 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 166 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 167 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 168 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 169 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 171 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 172 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 173 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 174 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 175 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 177 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 178 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 179 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 180 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 181 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 183 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 184 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 185 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 186 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 187 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 189 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 190 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 191 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 192 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 193 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 195 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 196 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 197 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 198 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 199 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 200 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 202 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 203 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 204 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 205 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 206 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 208 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 209 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 210 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 211 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 212 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 214 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018-2030 (USD MILLION)
  • TABLE 215 MAJOR PLAYERS IN THE GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
  • TABLE 216 MOST ACTIVE PLAYERS IN THE GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
  • TABLE 217 PRODUCT LAUNCH/PRODUCT APPROVAL
  • TABLE 218 MERGER & ACQUISITIONS
  • TABLE 219 AGREEMENT/MARKETING STRATEGIES
  • TABLE 220 ALLSCRIPTS HEALTHCARE, LLC: SERVICES OFFERED
  • TABLE 221 ALLSCRIPTS HEALTHCARE, LLC: KEY DEVELOPMENTS
  • TABLE 222 CERNER CORPORATION: PRODUCTS OFFERED
  • TABLE 223 DATASCAN PHARMACY: PRODUCTS OFFERED
  • TABLE 224 EPICOR SOFTWARE CORPORATION: PRODUCTS OFFERED
  • TABLE 225 GLOBEMED GROUP: PRODUCTS OFFERED
  • TABLE 226 LIBERTY SOFTWARE, INC.: PRODUCTS OFFERED
  • TABLE 227 LS RETAIL EHF.: PRODUCTS OFFERED
  • TABLE 228 MCKESSON CORPORATION: PRODUCTS OFFERED
  • TABLE 229 MCKESSON CORPORATION: KEY DEVELOPMENTS
  • TABLE 230 MEDHOK, INC.: PRODUCTS OFFERED
  • TABLE 231 OCTAL IT SOLUTION LLP.: PRODUCTS OFFERED
  • TABLE 232 SAFECARE TECHNOLOGY: PRODUCTS OFFERED
  • TABLE 233 SCRIPTPRO LLC: PRODUCTS OFFERED
  • TABLE 234 CLANWILLIAM HEALTH: PRODUCTS OFFERED
  • TABLE 235 CLANWILLIAM HEALTH: KEY DEVELOPMENTS
  • TABLE 236 MOBILE MEDSOFT: PRODUCTS OFFERED
  • TABLE 237 HEALTHCARE BUSINESS SYSTEMS, INC.: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
  • FIGURE 5 DRIVER IMPACT ANALYSIS
  • FIGURE 6 RESTRAINT IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN: GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: PHARMACY MANAGEMENT SYSTEM MARKET
  • FIGURE 9 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2021 & 2030 (USD MILLION)
  • FIGURE 10 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY COMPONENT, 2021 & 2030 (USD MILLION)
  • FIGURE 11 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2021 & 2030 (USD MILLION)
  • FIGURE 12 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2021 & 2030 (USD MILLION)
  • FIGURE 13 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET SHARE (%), BY REGION, 2021
  • FIGURE 14 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET SHARE, BY REGION 2021 (%)
  • FIGURE 15 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET SHARE, BY REGION 2021 (%)
  • FIGURE 16 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET SHARE, BY REGION 2021 (%)
  • FIGURE 17 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET SHARE, BY REGION 2021 (%)
  • FIGURE 18 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS SHARE, BY COUNTRY 2021 (%)
  • FIGURE 19 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS SHARE, BY COUNTRY 2021 (%)
  • FIGURE 20 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 21 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET
  • FIGURE 22 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 23 ALLSCRIPTS HEALTHCARE, LLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 24 ALLSCRIPTS HEALTHCARE, LLC: SWOT ANALYSIS
  • FIGURE 25 CERNER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 26 CERNER CORPORATION: SWOT ANALYSIS
  • FIGURE 27 EPICOR SOFTWARE CORPORATION: SWOT ANALYSIS
  • FIGURE 28 GLOBEMED GROUP: SWOT ANALYSIS
  • FIGURE 29 MCKESSON CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 30 MCKESSON CORPORATION: SWOT ANALYSIS
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!